it was me. I sold out the rest of my position. Out for now. Because PBT2 is not on their radar and ATH434 is a good 2 years away. Even Phase 2 first patient dosing will probably be end of 3rd quarter 2022 + add 1 year to that. From now to end of 2023, they’ll probably do a reverse split to get above 1, then as soon as the SP improve from split, they’ll probably do a dilution to raise money for trials, both of which are not good for SP.
it was me. I sold out the rest of my position. Out for now....
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $5.503K | 1.808M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 56169934 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 123932868 | 21 |
View Market Depth
| Last trade - 12.21pm 03/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |